Published in Kidney Int on January 01, 1997
The IL-23/Th17 axis contributes to renal injury in experimental glomerulonephritis. J Am Soc Nephrol (2009) 2.06
Resistance of Fc receptor- deficient mice to fatal glomerulonephritis. J Clin Invest (1998) 1.88
Lack of chemokine receptor CCR1 enhances Th1 responses and glomerular injury during nephrotoxic nephritis. J Clin Invest (1999) 1.84
CCR7 deficiency exacerbates injury in acute nephritis due to aberrant localization of regulatory T cells. J Am Soc Nephrol (2009) 1.79
Macrophages and immunologic inflammation of the kidney. Semin Nephrol (2010) 1.71
The Th17-defining transcription factor RORγt promotes glomerulonephritis. J Am Soc Nephrol (2010) 1.67
Th1 and Th17 cells induce proliferative glomerulonephritis. J Am Soc Nephrol (2009) 1.55
Crescentic glomerulonephritis in CD4- and CD8-deficient mice. Requirement for CD4 but not CD8 cells. Am J Pathol (1998) 1.44
P-selectin deficiency exacerbates experimental glomerulonephritis: a protective role for endothelial P-selectin in inflammation. J Clin Invest (1999) 1.42
Anti-inflammatory and renal protective actions of stanniocalcin-1 in a model of anti-glomerular basement membrane glomerulonephritis. Am J Pathol (2009) 1.35
Latent TGF-beta1 protects against crescentic glomerulonephritis. J Am Soc Nephrol (2008) 1.33
Multiphoton imaging reveals a new leukocyte recruitment paradigm in the glomerulus. Nat Med (2012) 1.23
T-bet deficiency attenuates renal injury in experimental crescentic glomerulonephritis. J Am Soc Nephrol (2008) 1.20
Mammalian stanniocalcin-1 activates mitochondrial antioxidant pathways: new paradigms for regulation of macrophages and endothelium. Am J Physiol Renal Physiol (2009) 1.12
Glomerulonephritis, Th1 and Th2: what's new? Clin Exp Immunol (2005) 1.10
Leukocyte-derived interleukin-1beta interacts with renal interleukin-1 receptor I to promote renal tumor necrosis factor and glomerular injury in murine crescentic glomerulonephritis. Am J Pathol (2004) 1.06
Fc gamma RIII and Fc gamma RIV are indispensable for acute glomerular inflammation induced by switch variant monoclonal antibodies. J Immunol (2008) 1.04
Leptin-deficient mice are protected from accelerated nephrotoxic nephritis. Am J Pathol (2004) 0.99
Focal and segmental glomerulosclerosis induced in mice lacking decay-accelerating factor in T cells. J Clin Invest (2009) 0.96
Major histocompatibility complex class II expression by intrinsic renal cells is required for crescentic glomerulonephritis. J Exp Med (1998) 0.96
Deletion of the fcgamma receptor IIb in thymic stromal lymphopoietin transgenic mice aggravates membranoproliferative glomerulonephritis. Am J Pathol (2003) 0.92
The IL-27 receptor has biphasic effects in crescentic glomerulonephritis mediated through Th1 responses. Am J Pathol (2011) 0.86
Interleukin-17A promotes early but attenuates established disease in crescentic glomerulonephritis in mice. Am J Pathol (2011) 0.86
Endogenous CD100 promotes glomerular injury and macrophage recruitment in experimental crescentic glomerulonephritis. Immunology (2009) 0.86
A Lectin-EGF antibody promotes regulatory T cells and attenuates nephrotoxic nephritis via DC-SIGN on dendritic cells. J Transl Med (2013) 0.82
IL-6 Trans-Signaling Drives Murine Crescentic GN. J Am Soc Nephrol (2015) 0.82
The ins and outs of glomerular crescent formation. Clin Exp Immunol (1997) 0.81
Tim3 is upregulated and protective in nephrotoxic serum nephritis. Am J Pathol (2010) 0.81
Involvement of MCP-1 in tubulointerstitial fibrosis through massive proteinuria in anti-GBM nephritis induced in WKY rats. J Clin Immunol (2007) 0.77
Altered distribution of intraglomerular immune complexes in C3-deficient mice. Immunology (1999) 0.77
Cryptococcosis associated with crescentic glomerulonephritis. Pediatr Nephrol (2008) 0.77
CD28 superagonist-induced regulatory T cell expansion ameliorates mesangioproliferative glomerulonephritis in rats. Clin Exp Nephrol (2010) 0.77
Effects of CTLA4-Fc on glomerular injury in humorally-mediated glomerulonephritis in BALB/c mice. Clin Exp Immunol (2002) 0.76
MHC class I pathway is not required for the development of crescentic glomerulonephritis in mice. Clin Exp Immunol (2000) 0.76
Signal transducer and activation of transcription 6 (STAT6) regulates T helper type 1 (Th1) and Th17 nephritogenic immunity in experimental crescentic glomerulonephritis. Clin Exp Immunol (2011) 0.76
Severe Nephrotoxic Nephritis following Conditional and Kidney-Specific Knockdown of Stanniocalcin-1. PLoS One (2015) 0.75
Granulomatous transformation of capillary lesions in pulmonary-renal syndrome autologously induced anti-glomerular basement membrane disease in Wistar-Kyoto rats. Clin Exp Nephrol (2010) 0.75
Abrogation of macrophage-dependent injury in experimental glomerulonephritis in the rabbit. Use of an antimacrophage serum. J Clin Invest (1981) 2.41
Macrophage migration inhibitory factor in rheumatoid arthritis: evidence of proinflammatory function and regulation by glucocorticoids. Arthritis Rheum (1999) 2.17
Prominence of cell-mediated immunity effectors in "pauci-immune" glomerulonephritis. J Am Soc Nephrol (1999) 2.11
Tissue culture of isolated glomeruli in experimental crescentic glomerulonephritis. J Exp Med (1978) 2.02
The macrophagen in human rapidly progressive glomerulonephritis. Lancet (1976) 1.88
Th1 and Th2 T helper cell subsets affect patterns of injury and outcomes in glomerulonephritis. Kidney Int (1999) 1.55
Tumor necrosis factor production by glomerular macrophages in anti-glomerular basement membrane glomerulonephritis in rabbits. Lab Invest (1991) 1.49
Role of CFTR mutations in adult bronchiectasis. Thorax (2004) 1.46
Protease-activated receptor 1 mediates thrombin-dependent, cell-mediated renal inflammation in crescentic glomerulonephritis. J Exp Med (2000) 1.44
Involvement of macrophage migration inhibitory factor in the evolution of rat adjuvant arthritis. Arthritis Rheum (1998) 1.39
Plasminogen and plasminogen activators protect against renal injury in crescentic glomerulonephritis. J Exp Med (1997) 1.38
T lymphocyte participation in antibody-induced experimental glomerulonephritis. Kidney Int (1985) 1.36
Antibody independent crescentic glomerulonephritis in mu chain deficient mice. Kidney Int (1997) 1.35
Participation of cell-mediated immunity in deposition of fibrin in glomerulonephritis. Lancet (1988) 1.32
Macrophage-induced glomerular fibrin deposition in experimental glomerulonephritis in the rabbit. J Clin Invest (1985) 1.31
The macrophage in the development of experimental crescentic glomerulonephritis. Studies using tissue culture and electron microscopy. Am J Pathol (1979) 1.31
The effect of defibrination on macrophage participation in rabbit nephrotoxic nephritis: studies using glomerular culture and electronmicroscopy. Clin Exp Immunol (1979) 1.28
IFN-gamma mediates crescent formation and cell-mediated immune injury in murine glomerulonephritis. J Am Soc Nephrol (1999) 1.27
Mechanisms of T cell-induced glomerular injury in anti-glomerular basement membrane (GBM) glomerulonephritis in rats. Clin Exp Immunol (1997) 1.25
Tissue factor and factor VIIa receptor/ligand interactions induce proinflammatory effects in macrophages. Blood (1999) 1.25
Immune modulation with interleukin-4 and interleukin-10 prevents crescent formation and glomerular injury in experimental glomerulonephritis. Eur J Immunol (1997) 1.23
Evidence for delayed-type hypersensitivity mechanisms in glomerular crescent formation. Kidney Int (1994) 1.23
P-selectin directs T lymphocyte-mediated injury in delayed-type hypersensitivity responses: studies in glomerulonephritis and cutaneous delayed-type hypersensitivity. Eur J Immunol (1996) 1.19
Crescentic glomerulonephritis is diminished in fibrinogen-deficient mice. Am J Physiol Renal Physiol (2001) 1.19
A role for P selectin in complement-independent neutrophil-mediated glomerular injury. Kidney Int (1994) 1.16
TLR9 and TLR4 are required for the development of autoimmunity and lupus nephritis in pristane nephropathy. J Autoimmun (2010) 1.16
Endogenous interleukin-10 regulates Th1 responses that induce crescentic glomerulonephritis. Kidney Int (2000) 1.15
Tissue culture of isolated human glomeruli. Pathology (1978) 1.15
Procoagulant activity expression by macrophages from atheromatous vascular plaques. Atherosclerosis (1989) 1.15
Glomerular procoagulant activity in human proliferative glomerulonephritis. J Clin Invest (1988) 1.14
Detection of intracellular lipocortin 1 in human leukocyte subsets. Clin Immunol Immunopathol (1995) 1.08
Diagnosis of Mycobacterium tuberculosis infection using ESAT-6 and intracellular cytokine cytometry. Clin Exp Immunol (2005) 1.07
Cellular immune mechanisms in human glomerulonephritis: the role of mononuclear leucocytes. Springer Semin Immunopathol (1982) 1.07
The participation of macrophages and monocytes in experimental immune complex glomerulonephritis. Clin Immunol Immunopathol (1980) 1.06
Macrophage-induced glomerular injury. Cell transfer studies in passive autologous antiglomerular basement membrane antibody-initiated experimental glomerulonephritis. Lab Invest (1984) 1.06
Antiinflammatory effect of lipocortin 1 in experimental arthritis. Inflammation (1997) 1.05
Glomerular interleukin 1 production is dependent on macrophage infiltration in anti-GBM glomerulonephritis. Kidney Int (1991) 1.04
Interleukin-8 production by macrophages from atheromatous plaques. Arterioscler Thromb Vasc Biol (1996) 1.04
Glomerular tissue factor expression in crescentic glomerulonephritis. Correlations between antigen, activity, and mRNA. Am J Pathol (1995) 1.02
Interleukin-4 deficiency enhances Th1 responses and crescentic glomerulonephritis in mice. Kidney Int (1998) 1.01
IL-12 directs severe renal injury, crescent formation and Th1 responses in murine glomerulonephritis. Eur J Immunol (1999) 1.01
Anti-neutrophil monoclonal antibody therapy inhibits the development of adjuvant arthritis. Clin Exp Immunol (1997) 1.00
Cell characteristics of cultured glomeruli from different animal species. Nephron (1978) 0.99
Interleukin-4 and interleukin-10 attenuate established crescentic glomerulonephritis in mice. Kidney Int (1997) 0.98
The participation of macrophages, glomerular procoagulant activity, and factor VIII in glomerular fibrin deposition. Studies on anti-GBM antibody-induced glomerulonephritis in rabbits. Am J Pathol (1986) 0.98
Hydroxyl radical mediation of immune renal injury by desferrioxamine. Kidney Int (1986) 0.97
Effect of cyclosporin A on antibody-induced experimental glomerulonephritis. Nephron (1985) 0.97
The effect of maintenance dialysis on lymphocyte function. I. Haemodialysis. Clin Exp Immunol (1978) 0.96
Interleukin-10 inhibits macrophage-induced glomerular injury. J Am Soc Nephrol (2000) 0.96
Lymphokine (MIF) production by glomerular T-lymphocytes in experimental glomerulonephritis. Kidney Int (1986) 0.96
Major histocompatibility complex class II expression by intrinsic renal cells is required for crescentic glomerulonephritis. J Exp Med (1998) 0.96
A comparison of fibrinolytic and defibrinating agents in established experimental glomerulonephritis. Br J Exp Pathol (1986) 0.93
Cyclosporine treatment reduces early atherosclerosis in the cholesterol-fed rabbit. Atherosclerosis (1995) 0.92
Interleukin-10 inhibits experimental mesangial proliferative glomerulonephritis. Clin Exp Immunol (2002) 0.92
Tissue culture of isolated glomeruli from patients with glomerulonephritis. Kidney Int (1980) 0.92
Decreased plasma tissue factor pathway inhibitor in women taking combined oral contraceptives. Am J Hematol (1999) 0.91
Pulmonary manifestations of the clinical syndrome of acute glomerulonephritis and lung hemorrhage. Am J Kidney Dis (1986) 0.91
IL-18 has IL-12-independent effects in delayed-type hypersensitivity: studies in cell-mediated crescentic glomerulonephritis. J Immunol (2000) 0.90
Alveolar macrophage procoagulant activity is increased in acute hyperoxic lung injury. Am J Pathol (1988) 0.90
Crescentic glomerulonephritis--a manifestation of a nephritogenic Th1 response? Histol Histopathol (2000) 0.90
Tissue factor initiates glomerular fibrin deposition and promotes major histocompatibility complex class II expression in crescentic glomerulonephritis. Am J Pathol (1997) 0.89
Glomerular macrophages produce reactive oxygen species in experimental glomerulonephritis. Kidney Int (1989) 0.89
Evidence for direct renal injury as a consequence of glomerular complement activation. J Immunol (1986) 0.89
Clinicopathological associations in mesangial IgA nephropathy. Am J Nephrol (1986) 0.88
Differential effects of steroids on leukocyte-mediated glomerulonephritis in the rabbit. Kidney Int (1984) 0.88
Acute lithium intoxication. Anaesth Intensive Care (2002) 0.88
Th2 responses induce humorally mediated injury in experimental anti-glomerular basement membrane glomerulonephritis. J Am Soc Nephrol (1997) 0.88
Granulocyte independence of pulmonary oxygen toxicity in the rat. Exp Lung Res (1989) 0.88
Prolonged antibiotic peritoneal lavage in the management of gross generalized peritonitis. Med J Aust (1976) 0.87
Glomerular fibrinolytic activity in anti-GBM glomerulonephritis in rabbits. Kidney Int (1993) 0.87